Navigation Links
FHSSA and the African Palliative Care Association Launch the First-Ever Pain Management Initiative in The Gambia, Kenya, and Malawi
Date:2/9/2011

ALEXANDRIA, Va., Feb. 9, 2011 /PRNewswire-USNewswire/ -- With generous funding totaling more than $220,000 FHSSA and the African Palliative Care Association are partnering to improve pain management among palliative care patients receiving care in hospitals in The Gambia, Kenya, and Malawi.

These three countries were selected because they each have well-established national palliative care organizations, strong clinical leadership, historical success with related projects, and sound professional relationships with APCA and FHSSA staff/leadership.

FHSSA's executive director, John Mastrojohn, traveled to Uganda this week to participate in kick-off meetings for the project.

FHSSA and APCA identified a set of challenges for the management of pain in The Gambia, Kenya, and Malawi. Hospital-based health care workers sometimes have a limited understanding of the palliative care concept and the need for palliative care services.

"Often, physicians are not comfortable in effectively prescribing opioids, such as morphine. This can be due to lack of skills in pain assessment and management, coupled with fears around the use of these powerful medications," said Mastrojohn.

The project framework is based on the success of a pilot project in Uganda that was endorsed by the World Health Organization and the Ugandan Ministry of Health. Objectives include:

  1. To create awareness of, support for and prioritization of palliative care delivery among hospital management/administrators.
  2. To train hospital physicians in pain assessment and management, with a central focus on opioid use.
  3. To sensitize other health care workers in the hospitals and community to support palliative care service delivery.

Funding was provided by Astellas Pharma US, Inc. , AstraZeneca Pharmaceuticals LP, Daiichi Sankyo, Inc., Endo Pharmaceuticals Inc., Lundbeck Inc, OSI Pharmaceuticals Inc., Pharmaceutical Research and Manufacturers of America (PhRMA), Grunenthal, and The Brin Wojcicki Foundation.

Learn more about the work of FHSSA at www.fhssa.org.

The Winter issue of FHSSA's "Focus on Compassion" newsletter is available online at http://www.fhssa.org/files/public/Quarterly/Focus_Winter_2011.pdf. Contact:Susan MessinaDirector of Communications and Special EventsOffice of Philanthropy (National Hospice Foundation and FHSSA)571-275-4324smessina@nationalhospicefoundation.org
'/>"/>

SOURCE FHSSA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
2. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
3. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
8. Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School
9. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
10. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
11. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)... 24, 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei ... ‚ausgezeichneter plus guter , ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) ... positive Daten von der MORA-Studie der Phase III ...
(Date:5/24/2016)... ARANZ Medical  Ltd a specialist ... has been named the Coretex Hi-Tech Emerging Company of the ... Dr Bruce Davey , CEO of ARANZ Medical says, ... good to be recognised for the work we are doing ... in 35 countries around the world from Sub-Saharan Africa through ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... In 1980, Bill Howe opened ... throughout the beach community. His vision to grow the company was built on a ... maintain the highest level of training and customer service. Over 35 years later, Bill ...
(Date:5/26/2016)... ... May 26, 2016 , ... Women’s athletic apparel company ... second pop-up shop for three consecutive weekends. The pop-up shop is a great ... community, a community full of women who appreciate the most premium goods and ...
(Date:5/25/2016)... ... May 26, 2016 , ... The 12th session of the Silicon ... at HP in Palo Alto, CA. This Bay Area biotech event will focus on ... trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract Research Organization (CRO) Experien ...
(Date:5/25/2016)... ... May 25, 2016 , ... Furthering its position as ... The National Center for Drug Free Sport (Drug Free Sport®) is excited to expand ... to be held July 12 – 13 in Kansas City, MO, will gather sports ...
(Date:5/25/2016)... ... 25, 2016 , ... One Florida-based plastic surgeon’s enthusiasm is proving to be ... published May 13th on Vanity Fair. In fact, as the article explains, more ... broadcast to more than 800,000 Snapchat fans. Commenting on this trend, Dr. Michael Salzhauer, ...
Breaking Medicine News(10 mins):